ZEZjala Ebadi

Zjala Ebadi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zjala Ebadi has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Real-Time Symptom Ratings Using Ecological Momentary Assessment Versus Traditional Questionnaires in Patients With Chronic Obstructive Pulmonary Disease: Observational Study

    by Banchia Palmen, Maarten van Herck, Yvonne M J Goërtz, Zjala Ebadi, Qichen Deng, Melissa S Y Thong, Chris Burtin, Jeannette B Peters, Roy T M Sprooten, Erik W M A Bischoff, et al.

    Background: Questionnaires assessing symptoms in chronic obstructive pulmonary disease (COPD) rely on retrospective reporting, introducing recall bias and missing symptom variability. Ecological momentary assessment (EMA) addresses these limitations by capturing real-time symptom data. Objective: The aim of this study was to compare EMA symptom ratings with traditional questionnaires in patients with COPD. Methods: A subsample from the FAntasTIGUE study rated symptoms using questionnaires (visual analog scale, modified Medical Research Council Dyspnea Scale, Physical Activity Rating Scale-Dyspnea Questionnaire, Checklist Individual Strength-subscale Subjective Fatigue, Hospital Anxiety and Depression Scale, and COPD Assessment Test) and EMA. Participants rated breathlessness, fatigue, anxiety, and energy level on a 7-point Likert scale during 8 random EMA prompts daily for 5 days. Results: Among 54 participants (mean age 67, SD 7 y; forced expiratory volume in 1 s 53%, SD 20% predicted; n=35, 65% men), the EMA response rate was 76.1%. EMA scores were moderately to strongly correlated with questionnaire scores ( r s =0.49-0.78, all P <.05) and varied across severity groups (all P <.05). EMA captured significant intraday and interday symptom variability. Conclusions: EMA is a valid tool for COPD symptom assessment, capturing real-time fluctuations to improve symptom management.


  • Open Access

    Ecological Momentary Assessment to Measure Diurnal and Between-day Symptom Variability in Patients With COPD: A Longitudinal Observational Study (Preprint)

    by Banchia Palmen, Anouk W Vaes, Qichen Deng, Maarten van Herck, Zjala Ebadi, Melissa Sy Thong, Chris Burtin, Jeannette B Peters, Roy Tm Sprooten, Erik Wma Bischoff, et al.

    BACKGROUND Symptoms in chronic obstructive pulmonary disease (COPD) fluctuate not only across days and seasons but also within a single day (diurnal). Conventional retrospective questionnaires are limited in capturing such temporal dynamics. Ecological Momentary Assessment (EMA) provides real-time data and may advance understanding of diurnal, between-day and context-dependent symptom variability in COPD. OBJECTIVE To examine diurnal and between-day variations in ten common symptoms in COPD and to explore their interrelationships, and associations with activity, location, and social company using EMA. It was hypothesized that most symptoms will peak during morning hours. METHODS Baseline data from patients participating in a multicenter observational study (FAntasTIGUE) were analyzed. Patients completed EMA assessments 8 times daily for 5 consecutive days, rating ten symptoms/mood states on a 7-point Likert scale. Multilevel linear mixed-effects models were used to assess diurnal and between-day variation and interactions with contextual factors (activity, location, and social company). Variance components and vector autoregressive (VAR) models were applied to examine within- versus between-person variability and temporal interrelationships. RESULTS A total of 1,996 valid EMA assessments from 52 patients with COPD (mean age 67±7 years, 67% male) were analyzed. Most assessments occurred at home (78%), typically while relaxing (27%), and participants were most often accompanied by a partner (43%) or alone (39%). A significant diurnal increase was observed for feeling tired, relaxed and satisfied throughout the day, whereas feeling energetic, short of breath, and irritated decreased (P<.05). Between-day variability was significant for feeling insecure and anxious. Compared with relaxing, feeling energetic showed a smaller diurnal decline during ‘other’ activities, while shortness of breath declined less across the day during resting. Patients reported greater cheerfulness when eating/drinking and higher insecurity when doing nothing. Anxiety increased across the day when doing nothing or engaging in sports, but decreased during eating/drinking. Being outside the home was associated with greater increases in relaxation and satisfaction over the day. Variance components showed that tiredness, relaxation, and irritation fluctuated more within-persons (≈51%), while feeling cheerful, mentally fit, and anxious varied mainly between-persons (≈67%). VAR analyses revealed minimal temporal interdependence among symptoms, suggesting that most symptoms evolved independently. CONCLUSIONS Symptoms in COPD exhibit distinct diurnal and between-day variability, with several symptoms decreasing rather than peaking during morning hours. EMA provides unique insights into how activity, location, and social company influence symptom trajectories, highlighting opportunities for personalized treatment timing and targeted self-management strategies.

  • Fatigue in COPD: a Longitudinal, Multidimensional Perspective

    by Zjala Ebadi, Yvonne M. J. Goërtz, Maarten Van Herck, Marc J. M. H. Delsing, Chris Burtin, Bram van Den Borst, Melissa S. Y. Thong, Erik W. M. A. Bischoff, Jean W. M. Muris, Judith Prins, et al.

    Background Fatigue is a pervasive, debilitating symptom of chronic obstructive pulmonary disease (COPD) that significantly impacts patients’ overall health and quality of life. However, its underlying mechanisms and associations with physical, psychological, behavioral, and other health factors remain unclear. This study investigated longitudinal associations between fatigue and these factors in COPD. Method A total of 247 COPD patients (mean age, 67.3 ± 8.1 years; 60% male; mean forced expiratory volume in 1 s (FEV1) 57 ± 21% predicted) from primary and secondary care were enrolled in a longitudinal observational study. Two-wave autoregressive cross-lagged panel models (ARCLM) examined relationships between fatigue and associated factors at baseline and 1 year later. Results Severe fatigue was prevalent in 53% of participants at baseline, with no significant change at follow-up. ARCLM findings indicated that baseline physical activity was the only predictor of reduced fatigue after 1 year. Moreover, higher baseline fatigue predicted poorer health-related quality of life, more severe dyspnea, and greater dyspnea-related emotional distress at follow-up. Although the initial focus was on fatigue, the analysis revealed a complex network of longitudinal relationships between multiple studied variables extending beyond fatigue. Conclusion Physical activity was the only direct predictor of fatigue, while fatigue directly influenced dyspnea, dyspnea-related emotions, and health-related quality of life. This study highlights the important role of fatigue within a complex network of physical, psychological, health status, and behavioral factors. The complexity of the interrelatedness of these factors suggests that single-target interventions are unlikely to be effective. Rather, integrated interventions, such as pulmonary rehabilitation, are needed.


  • Open Access

    Bidirectional Associations Between Physical Activity, Sedentary Behavior, and Daily Symptoms in Patients With Chronic Obstructive Pulmonary Disease: Longitudinal Observational Study

    by Banchia Palmen, Zjala Ebadi, Maarten van Herck, Yvonne M J Goërtz, Qichen Deng, Melissa S Y Thong, Chris Burtin, Jeannette B Peters, Roy T M Sprooten, Erik W M A Bischoff, et al.

    Background: Questionnaire-based symptom assessment may introduce recall bias and lacks bidirectional exploration. This is particularly relevant, given the unclear direction of the associations between physical activity (PA), sedentary time (ST), and symptoms in patients with chronic obstructive pulmonary disease (COPD). Understanding these associations could inform symptom management strategies and improve patient quality of life. Objective: This study aimed to investigate the direction of the association between PA, ST, and symptoms in patients with COPD using accelerometry and ecological momentary assessment (EMA). Methods: A subsample from the FAntasTIGUE study answered 8 randomly timed EMA questionnaires daily for 5 days. Ten symptoms were rated on a 7-point Likert scale: “I feel relaxed, short of breath, energetic, cheerful, insecure, irritated, satisfied, anxious, tired, and mentally fit.” Concurrently, step count and ST were measured using the ActiGraph GT9X Link placed on the right hip. Step count and ST 15 and 30 minutes pre- and post-EMA were used in multilevel models, controlled for pre-EMA steps and ST, and the previous EMA score. Significant confounders were used as covariates, and patient ID was used as random intercept. Results: Thirty-four patients (19/34, 56% men, mean age 66, SD 7 years; forced expiratory volume in 1 second 52±20% predicted; 1035 EMA responses) were included. Feeling more relaxed was associated with a higher step count 15 minutes post-EMA (β=5.1; 95% CI 0.9 to 10.1; P =.046). Conversely, higher step count 15 and 30 minutes pre-EMA was associated with feeling less relaxed (β=−5.2×10 −4 ; 95% CI −9.7×10 −4 to −7.0×10 −5 ; P =.02; and β=−3.2×10 −4 ; 95% CI −5.6×10 −4 to −7.9×10 −5 ; P =.009), more short of breath (β=8.5×10 −4 ; 95% CI 4.7×10 −4 to 1.2×10 −3 ; P <.001; and β=4.6×10 −4 ; 95% CI 2.6×10 −4 to 6.6×10 −4 ; P <.001), and tired (β=5.1×10 −4 ; 95% CI 7.2×10 −5 to 9.4×10 −4 ; P =.02; and β=2.9×10 −4 ; 95% CI 5.3×10 −5 to 5.2×10 −4 ; P =.02). Higher ST 15 and 30 minutes pre-EMA was associated with feeling more anxious (β=1.7×10 −4 ; 95% CI 1.7×10 −5 to 3.2×10 −4 ; P =.03; and β=8.5×10 −5 ; 95% CI 2.5×10 −6 to 1.7×10 −4 ; P =.04). Conclusions: A bidirectional association of feeling relaxed with PA was found in patients with COPD. Higher step count was related to feeling more short of breath and tired, whereas higher ST was associated with heightened anxiety.


  • Open Access

    Associated factors of fatigue in patients with COPD: results from the FAntasTIGUE study

    by Maarten Van Herck, Yvonne M. J. Goërtz, Zjala Ebadi, Chris Burtin, Jeannette B. Peters, Melissa S. Y. Thong, R. Posthuma, J. W. M. Muris, E. W. M. A. Bischoff, Emiel F.M. Wouters, et al.

    Background: Fatigue is present in about half of the patients with COPD. The associated factors of fatigue in COPD remain unclear and have not been studied in an integrated and holistic analysis. The aim of this study is to identify associated factors of fatigue in COPD.Methods: In this cross-sectional study, clinically stable patients with COPD from primary and secondary care were assessed for fatigue (Checklist Individual Strength Subjective Fatigue; CIS-Fatigue), other symptoms, medication, and personal, COPD-related, physical, psychological, and systemic factors. Multivariable stepwise regression analyses were performed for each domain, followed by a multivariable (enter) model with all identified factors.Results: In total, 247 patients with COPD (67±8 years, 60% male, FEV1 57±21% predicted, 27% GOLD E) were included in the study of which 51% reported severe fatigue (CIS-Fatigue ≥36 points). Distinct models for each group of factors identified the following factors associated with a higher level of fatigue: living alone, antidepressant use, anxiolytic use, systemic antihistamines use, higher Charlson comorbidity score, lower diffusion capacity, higher number of moderate exacerbations in the last year, higher dyspnea, reduced sleep quality, higher pain, lower functional exercise capacity, higher fatigue-related catastrophizing, more depressive symptoms, lower calcium, and higher leukocyte count. The final model explained 46.6% of variance in fatigue with dyspnea, sleep quality, fatigue-catastrophizing, and pain as significant associated factors (F(17 184)=11.312, p<0.001).Conclusion: Pain, sleep quality, dyspnea and fatigue-catastrophizing were identified as associated factors of fatigue. These factors should not be overlooked when treating fatigue in patients with COPD.


  • Late Breaking Abstract - Post-Covid-19 fatigue and its associations with health status: long-term follow-up

    by Zjala Ebadi, Jeannette Peters, Bram Van Den Borst, Jan Vercoulen

    Background: Fatigue is frequently reported by patients after Covid-19. This study assessed prevalence and long term course of fatigue and its association with subdomains of health status (HS) after Covid-19. Methods: Between May 2020-May 2021 patients visited the multidisciplinary Covid-19 aftercare facility of the Radboudumc twice. We distinguished three groups: post-intensive care unit (ICU), hospitalized non-ICU and non-hospitalized patients referred by general practitioners for persisting symptoms. Fatigue was assessed using Checklist Individual Strength (severe fatigue ≥35). Subdomains of HS were measured with the Nijmegen Clinical Screening Instrument. Results: In total 236 patients; post-ICU: (n=31, 61±9 years, 23% female), hospitalized non-ICU (n=77, 62±13 years, 36% female), GP-referred (n=128, 51±14 years, 71% female) were included. Severe fatigue was present in 58% of ICU, 66% of hospitalized and in 94% of GP-referred patients at the first (3.7±1.6 months) and respectively 52%, 64% and 75% at the second consultation (8.2±2.1 months), with only a significant decrease in number of patients with severe fatigue in GP-referred patients. Correlations between fatigue and subdomains of HS at first consultation and change between first and second consultation were all significant, strongest with subjective impairment and health related quality of life (all r>0.57, p<0.001). Conclusions: Severe fatigue remains highly prevalent in both hospitalized patients and non-hospitalized patients even up to 10 months after Covid-19 and is accompanied with problems in other sub-domains of HS. Future studies should focus on tailored treatments that alleviate and prevent fatigue after Covid-19 to become chronic.

  • Open Access

    The prevalence and related factors of fatigue in patients with COPD: a systematic review

    by Zjala Ebadi, Yvonne M.J. Goërtz, Maarten Van Herck, Daisy J.A. Janssen, Martijn A. Spruit, Chris Burtin, Melissa S.Y. Thong, Jean Muris, Jacqueline Otker, Milou Looijmans, et al.

    Background: Fatigue is a distressing symptom in patients with COPD. Little is known about the factors that contribute to fatigue in COPD. This review summarises existing knowledge on the prevalence of fatigue, factors related to fatigue and the instruments most commonly used to assess fatigue in COPD.Methods: Pubmed, PsycINFO, EMBASE, Cochrane and CINAHL databases were searched for studies from inception up to 7 January 2020 using the medical subject headings “COPD” and “Fatigue”. Studies were reviewed in accordance with PRISMA guidelines.Results: 196 studies were evaluated. The prevalence of fatigue ranged from 17–95%. Age (r=−0.23 to r=0.27), sex (r=0.11), marital status (r=−0.096), dyspnoea (r=0.13 to r=0.78), forced expiatory volume in 1 s % predicted (r=−0.55 to r=−0.076), number of exacerbations (r=0.27 to r=0.38), number of comorbidities (r=0.10), number of medications (r=0.35), anxiety (r=0.36 to r=0.61), depression (r=0.41 to r=0.66), muscle strength (r=−0.78 to r=−0.45), functional capacity (r=−0.77 to r=−0.14) and quality of life (r=0.48 to r=0.77) showed significant associations with fatigue.Conclusions: Fatigue is a prevalent symptom in patients with COPD. Multiple physical and psychological factors seem to be associated with fatigue.Future studies are needed to evaluate these underlying factors in integral analyses in samples of patients with COPD.


  • Open Access

    Pulmonary Rehabilitation Reduces Subjective Fatigue in COPD: A Responder Analysis

    by Maarten Van Herck, Jeanine Antons, Jan H. Vercoulen, Yvonne M. J. Goërtz, Zjala Ebadi, Chris Burtin, Daisy J. A. Janssen, Melissa S. Y. Thong, Jacqueline Otker, Arnold Coors, et al.

    To date, it remains unknown which patients report a clinically-relevant improvement in fatigue following pulmonary rehabilitation (PR). The purpose of this study was to identify and characterize these responders. Demographics, lung function, anxiety (anxiety subscale of the 90-item symptom checklist (SCL-90-A)), depression (Beck depression inventory for primary care (BDI-PC)), exercise tolerance (six-minute walking distance test (6MWD)), and health status (Nijmegen clinical screening instrument (NCSI)) were assessed before and after a 12-week PR programme. Fatigue was assessed using the checklist individual strength (CIS)-Fatigue. Patients with a decline ≥ 10 points (minimally clinically important difference, MCID) on the CIS-Fatigue were defined as responders. Chronic obstructive pulmonary disease (COPD) patients (n = 446, 61 ± 9 years, 53% male, forced expiratory volume in 1 s (FEV1) 43% ± 18% predicted, 75% severe fatigue) were included. Mean change in fatigue after PR was 10 ± 12 points (p < 0.01) and exceeded the MCID. In total, 56% were identified as fatigue responders. Baseline CIS-Fatigue (45 ± 7 vs. 38 ± 9 points, respectively, p < 0.001) and health-related quality-of-life (HRQoL; p < 0.001) were different between responders and non-responders. No differences were found in demographics, baseline anxiety, depression, lung function, 6MWD, and dyspnoea (p-values > 0.01). Responders on fatigue reported a greater improvement in anxiety, depression, 6MWD, dyspnoea (all p-values < 0.001), and most health status parameters. PR reduces fatigue in COPD. Responders on fatigue have worse fatigue and HRQoL scores at baseline, and are also likely to be responders on other outcomes of PR.


  • Open Access

    Fatigue is Highly Prevalent in Patients with Asthma and Contributes to the Burden of Disease

    by Maarten Van Herck, Martijn A. Spruit, Chris Burtin, Remco Djamin, Jeanine Antons, Yvonne M. J. Goërtz, Zjala Ebadi, Daisy J. A. Janssen, Jan H. Vercoulen, Jeannette B. Peters, et al.

    The 2018 update of the Global Strategy for Asthma Management and Prevention does not mention fatigue-related symptoms. Nevertheless, patients with asthma frequently report tiredness, lack of energy, and daytime sleepiness. Quantitative research regarding the prevalence of fatigue in asthmatic patients is lacking. This retrospective cross-sectional study of outpatients with asthma upon referral to a chest physician assessed fatigue (Checklist Individual Strength-Fatigue (CIS-Fatigue)), lung function (spirometry), asthma control (Asthma Control Questionnaire (ACQ)), dyspnea (Medical Research Council (MRC) scale), exercise capacity (six-minute walk test (6MWT)), and asthma-related Quality-of-Life (QoL), Asthma Quality of Life Questionnaire (AQLQ) during a comprehensive health-status assessment. In total, 733 asthmatic patients were eligible and analyzed (47.4 ± 16.3 years, 41.1% male). Severe fatigue (CIS-Fatigue ≥ 36 points) was detected in 62.6% of patients. Fatigue was not related to airflow limitation (FEV1, ρ = −0.083); was related moderately to ACQ (ρ = 0.455), AQLQ (ρ = −0.554), and MRC (ρ = 0.435; all p-values < 0.001); and was related weakly to 6MWT (ρ = −0.243, p < 0.001). In stepwise multiple regression analysis, 28.9% of variance in fatigue was explained by ACQ (21.0%), MRC (6.5%), and age (1.4%). As for AQLQ, 42.2% of variance was explained by fatigue (29.8%), MRC (8.6%), exacerbation rate (2.6%), and age (1.2%). Severe fatigue is highly prevalent in asthmatic patients; it is an important determinant of disease-specific QoL and a crucial yet ignored patient-related outcome in patients with asthma.